2365306-62-1
英文名稱(chēng)
2-Pyridinecarboxamide, N-[6-[(3R,6R)-5-amino-3,6-dihydro-3,6-dimethyl-6-(trifluoromethyl)-2H-1,4-oxazin-3-yl]-5-fluoro-2-pyridinyl]-3-chloro-5-(trifluoromethyl)-, hydrochloride (1:1)
CAS
2365306-62-1
分子式
C19H16Cl2F7N5O2
分子量
550.26
MOL 文件
2365306-62-1.mol
2365306-62-1 結(jié)構(gòu)式
基本信息
英文別名
Umibecestat HCl2-Pyridinecarboxamide, N-[6-[(3R,6R)-5-amino-3,6-dihydro-3,6-dimethyl-6-(trifluoromethyl)-2H-1,4-oxazin-3-yl]-5-fluoro-2-pyridinyl]-3-chloro-5-(trifluoromethyl)-, hydrochloride (1:1)
應(yīng)用領(lǐng)域
用途一
Umibecestat, also known as CNP-520, is a beta-secretase inhibitor and is a drug candidate for prevention trials in Alzheimer's disease. CNP520 has a selectivity, pharmacodynamics, and distribution profile suitable for AD prevention studies. CNP520 reduced brain and cerebrospinal fluid (CSF) Aβ in rats and dogs, and Aβ plaque deposition in APP-transgenic mice. CNP520 reduces Aβ load and neuroinflammation in APP‐transgenic mice